This is the first experimental in vivo study that shows that chronic treatment with ANP reduces cardiac oxidative stress, fibrosis, apoptosis and hypertrophy in a model of hypertension, increasing NO-system activity. The gene discussed is NPPA; the disease is Hypertension.